GYN:Other Cancer Clinical Trials

Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

The purpose of the study is to determine the overall response rate of single agent TRC105 and the combination of TRC105 and bevacizumab in patients with refractory GTN (including choriocarcinoma, p...

Diagnosis: GYN: Endometrial/Uterine Cancer, GYN:Other Cancer

Phase:

Protocol Number: 16-126